ARTICLE | Clinical News
Treximet sumatriptan/naproxen regulatory update
May 25, 2015 7:00 AM UTC
FDA approved an sNDA from Pernix for Treximet sumatriptan/naproxen to treat migraine with or without aura in patients ages 12-17. The combination of sumatriptan and naproxen is already approved in adu...